Compugen Ltd.
CGEN
$2.63
$0.041.54%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/18/2026
-
MarketBeat
8/31/2026
-
Zacks Investment Research
8/22/2026
-
MarketBeat
8/21/2026
-
Zacks Investment Research
8/16/2026
-
Simply Wall St
8/14/2026
-
MarketBeat
8/11/2026
-
Fool.com Headlines
8/7/2026
-
Seeking Alpha - Israel Stocks
8/7/2026
-
Seeking Alpha - Long Ideas
8/6/2026
-
MarketBeat
8/4/2026
-
TipRanks
8/4/2026
-
MarketBeat
8/4/2026
-
Simply Wall St
8/3/2026
-
SeekingAlpha
8/3/2026
-
Zacks Investment Research
8/3/2026
-
PR Newswire
7/31/2026
-
Seeking Alpha - Israel Stocks
7/21/2026
-
PR Newswire
7/20/2026
-
PR Newswire
7/18/2026
-
MarketBeat
7/10/2026
-
TipRanks: TheFly
7/10/2026
-
The Cerbat Gem
7/9/2026
-
MarketBeat
6/18/2026
-
PR Newswire
6/15/2026
-
SeekingAlpha
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Monday, August 3, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 3 765 8585
Address
Azrieli Center
Building D
26 Harokmim Street
Holon, 5885849
Building D
26 Harokmim Street
Holon, 5885849
Country
Year Founded
Business Description
Sector
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the...
more